5-LOXIN® is an extract of Boswellia serrata, which supports the preservation of cartilage, collagen and connective tissue in the Skeletal System.

It contains 30% 3-O-acetyl-11-keto-beta-boswellic acid (AKBA) which exhibits properties that support potential anti-inflammatory.

5-LOXIN® has multiple scientific studies that demonstrate efficacy starting at 7 days – with a low dosage.

The ingredient is supported by 13 pre-clinical and 2 human clinical trials. The proven efficacy was proven for a dose of only 100 mg/day.